|
|
|
Insider
Information: |
Kaplan Gilla Phd |
Relationship: |
|
City: |
Warren |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
165,924 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,258,820 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
165,924 |
|
|
Total
Value |
$8,258,820 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
|
2018-05-18 |
76,301 |
2015-01-02 |
0 |
Premium* |
|
Tyra Biosciences, Inc. |
TYRA |
|
2024-06-13 |
89,623 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
Director |
|
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
733 |
81,852 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-01 |
4 |
OE |
$28.97 |
$267,926 |
D/D |
9,250 |
82,359 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
82,734 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
83,067 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,068 |
83,642 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
734 |
83,801 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-09-12 |
4 |
OE |
$33.88 |
$313,390 |
D/D |
9,250 |
85,551 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-12-05 |
4 |
OE |
$24.97 |
$230,926 |
D/D |
9,250 |
85,551 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2018-02-15 |
4 |
S |
$95.99 |
$887,898 |
D/D |
(9,250) |
85,551 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,110 |
87,752 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
733 |
88,485 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-09-10 |
4 |
S |
$122.45 |
$1,836,750 |
D/D |
(15,000) |
88,485 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-12-21 |
4 |
AS |
$110.62 |
$1,600,008 |
D/D |
(14,464) |
88,485 |
0 |
- |
|
TYRA |
Tyra Biosciences, Inc. |
|
|
2024-06-13 |
4 |
OE |
$0.61 |
$37,449 |
D/D |
61,392 |
89,623 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-12-08 |
4 |
OE |
$7.09 |
$106,388 |
D/D |
15,000 |
94,508 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-02-26 |
4 |
OE |
$8.47 |
$127,020 |
D/D |
15,000 |
94,508 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-10 |
4 |
OE |
$9.93 |
$148,950 |
D/D |
15,000 |
94,508 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2018-02-15 |
4 |
OE |
$27.18 |
$251,415 |
D/D |
9,250 |
94,801 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-12-21 |
4 |
OE |
$16.21 |
$234,461 |
D/D |
14,464 |
102,949 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-09-10 |
4 |
OE |
$14.25 |
$213,750 |
D/D |
15,000 |
103,485 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2018-05-18 |
4 |
OE |
$30.01 |
$832,778 |
D/D |
27,750 |
104,051 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-09-08 |
4 |
OE |
$7.25 |
$217,425 |
D/D |
30,000 |
109,508 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2006-10-30 |
4 |
OE |
$1.30 |
$331,781 |
D/D |
123,996 |
123,996 |
0 |
- |
|
73 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|